UnitedHealth gains as insider buys spurs dip buying

8 hours ago 11

Frank DeMatteo

Fri, May 16, 2025, 1:26 PM 1 min read

The banal has been brutalized this week aft the institution suspended its 2025 outlook arsenic aesculapian expenditures are expected to beryllium higher than anticipated, the CEO stepped down for idiosyncratic reasons, and the WSJ reported the institution is nether a U.S. transgression probe for imaginable Medicare fraud.

Advertisement: High Yield Savings Offers

Just aft noon connected Wall Street, 3 consecutive SEC filings crossed the portion disclosing 3 abstracted insider purchases.

Director Kristen Gil bought 3,700 shares connected 05/15/25 astatine $271.17
Director Timothy Patrick Flynn bought 1,533 shares connected 05/14/25 astatine $320.80
Director John Noseworthy bought 300 shares connected 05/14/25 astatine $312.16

While comparatively small, the buys are intelligibly a concerted effort by the committee to instill assurance successful the banal aft the monolithic selloff

Despite this afternoon’s rally, the banal remains down 24% this week and down 50% this month.

Several Wall Street analysts person travel retired to support the banal amid the drastic sell-off.

Earlier today, Mizuho expert Ann Hnyes said, “… the unprecedented -28% diminution successful the banal (versus the S&P 500 scale +1.2%) implicit the past 3 trading days, makes the risk/reward charismatic successful our view.” They enactment the banal is trading astatine conscionable 12.5x the firm’s adjusted EPS estimates for 2025. The expert maintained an Outperform standing connected UnitedHealth, portion lowering their terms people to $350 from $515.

UnitedHealth gains arsenic insider buys spurs dip buying

Five TSX stocks that reported earnings, and what analysts are saying

Clean vigor taxation recognition connection affirmative for Sunrun - Clear Street

Read Entire Article